Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
DSRNA, USE THEREOF AND PREPARATION METHOD THEREFOR
Document Type and Number:
WIPO Patent Application WO/2023/138650
Kind Code:
A1
Abstract:
Provided are a dsRNA, a use thereof and a preparation method therefor. Also provided are a pharmaceutical composition comprising the dsRNA, a cell or a kit. The dsRNA can interfere with the expression of HSD17B13 to prevent and/or treat related diseases.

Inventors:
LIN XIAOYAN (CN)
DONG YUQIONG (CN)
ZHANG ZHEN (CN)
LI YUNFEI (CN)
WANG YANHUI (CN)
MAO SONG (CN)
ZHOU YAQIN (CN)
HUANG LONGFEI (CN)
HUANG YANFEN (CN)
HUANG MINYIN (CN)
Application Number:
PCT/CN2023/073096
Publication Date:
July 27, 2023
Filing Date:
January 19, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
TUOJIE BIOTECH SHANGHAI CO LTD (CN)
International Classes:
C12N15/113; A61K31/713; A61K48/00; A61P1/16
Foreign References:
CN112020556A2020-12-01
CN112423794A2021-02-26
CN113164509A2021-07-23
CN113544272A2021-10-22
Other References:
KUMAR SANTOSH; DUAN QIHUA; WU RONGXUE; HARRIS EDWARD N.; SU QIAOZHU: "Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis", ADVANCED DRUG DELIVERY REVIEWS, ELSEVIER, AMSTERDAM , NL, vol. 176, 16 July 2021 (2021-07-16), Amsterdam , NL , XP086773674, ISSN: 0169-409X, DOI: 10.1016/j.addr.2021.113869
Attorney, Agent or Firm:
GE CHENG & CO., LTD. (CN)
Download PDF: